Advertisement
Singapore markets closed
  • Straits Times Index

    3,224.01
    -27.70 (-0.85%)
     
  • S&P 500

    5,248.49
    +44.91 (+0.86%)
     
  • Dow

    39,760.08
    +477.75 (+1.22%)
     
  • Nasdaq

    16,399.52
    +83.82 (+0.51%)
     
  • Bitcoin USD

    70,784.72
    -525.95 (-0.74%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.06
    +20.08 (+0.25%)
     
  • Gold

    2,232.90
    +20.20 (+0.91%)
     
  • Crude Oil

    82.45
    +1.10 (+1.35%)
     
  • 10-Yr Bond

    4.2080
    +0.0120 (+0.29%)
     
  • Nikkei

    40,168.07
    -594.66 (-1.46%)
     
  • Hang Seng

    16,541.42
    +148.58 (+0.91%)
     
  • FTSE Bursa Malaysia

    1,530.60
    -7.82 (-0.51%)
     
  • Jakarta Composite Index

    7,288.81
    -21.28 (-0.29%)
     
  • PSE Index

    6,903.53
    +5.36 (+0.08%)
     

Compared to Estimates, Ecolab (ECL) Q4 Earnings: A Look at Key Metrics

Ecolab (ECL) reported $3.67 billion in revenue for the quarter ended December 2022, representing a year-over-year increase of 9.1%. EPS of $1.27 for the same period compares to $1.28 a year ago.

The reported revenue represents a surprise of +0.04% over the Zacks Consensus Estimate of $3.67 billion. With the consensus EPS estimate being $1.25, the EPS surprise was +1.60%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

ADVERTISEMENT

Here is how Ecolab performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Sales-Global Industrial: $1.87 billion compared to the $1.84 billion average estimate based on five analysts. The reported number represents a change of +10.1% year over year.

  • Sales-Global Institutional & Specialty: $1.16 billion versus $1.15 billion estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +8.7% change.

  • Sales-Other: $354.60 million versus $351.51 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +9.9% change.

  • Sales-Corporate: $27.70 million versus the four-analyst average estimate of $31.81 million.

  • Sales-Global Healthcare and Life Sciences: $431.10 million versus $375.63 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +40% change.

  • Operating Income -Corporate: -$152 million compared to the -$68.97 million average estimate based on five analysts.

  • Operating Income -Global Industrial: $283.80 million versus $291.78 million estimated by five analysts on average.

  • Operating Income -Global Institutional & Specialty: $172 million compared to the $178.01 million average estimate based on five analysts.

  • Operating Income -Other: $59.20 million compared to the $57.29 million average estimate based on five analysts.

  • Operating Income - Global Healthcare and Life Sciences: $67.70 million compared to the $38.96 million average estimate based on four analysts.

View all Key Company Metrics for Ecolab here>>>

Shares of Ecolab have returned -4.2% over the past month versus the Zacks S&P 500 composite's +3.6% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Ecolab Inc. (ECL) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research